Success Metrics

Clinical Success Rate
92.1%

Based on 35 completed trials

Completion Rate
92%(35/38)
Active Trials
14(19%)
Results Posted
6%(2 trials)
Terminated
3(4%)

Phase Distribution

Ph early_phase_1
1
1%
Ph not_applicable
40
56%
Ph phase_1
2
3%
Ph phase_3
3
4%
Ph phase_4
2
3%

Phase Distribution

3

Early Stage

0

Mid Stage

5

Late Stage

Phase Distribution48 total trials
Early Phase 1First-in-human
1(2.1%)
Phase 1Safety & dosage
2(4.2%)
Phase 3Large-scale testing
3(6.3%)
Phase 4Post-market surveillance
2(4.2%)
N/ANon-phased studies
40(83.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

92.1%

35 of 38 finished

Non-Completion Rate

7.9%

3 ended early

Currently Active

14

trials recruiting

Total Trials

72

all time

Status Distribution
Active(17)
Completed(35)
Terminated(3)
Other(17)

Detailed Status

Completed35
unknown17
Recruiting11
Terminated3
Active, not recruiting3
Enrolling by invitation2

Development Timeline

Analytics

Development Status

Total Trials
72
Active
14
Success Rate
92.1%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (2.1%)
Phase 12 (4.2%)
Phase 33 (6.3%)
Phase 42 (4.2%)
N/A40 (83.3%)

Trials by Status

recruiting1115%
terminated34%
unknown1724%
active_not_recruiting34%
not_yet_recruiting11%
enrolling_by_invitation23%
completed3549%

Recent Activity

Clinical Trials (72)

Showing 20 of 72 trialsScroll for more
NCT07446972

Impact of Bariatric Surgery on Female Sexual Function and Sex Hormones

Not Yet Recruiting
NCT07058155Phase 4

Optimizing Portal Hypertension With TIPS and Interval Metabolic Surgery for Advanced Liver Disease

Recruiting
NCT02390973Not Applicable

Surgery Versus Best Medical Management for the Long Term Remission of Type 2 Diabetes and Related Diseases (REMISSION)

Recruiting
NCT07263269Not Applicable

Comparing Dumping Symptoms and Quality of Life 6 Months After Sleeve Gastrectomy With or Without Transit Bipartition in Adults With Obesity

Active Not Recruiting
NCT05207917Not Applicable

How Does Bariatric Surgery Affect Social Experiences and Well-being - The BaSES-study

Enrolling By Invitation
NCT05777928Not Applicable

Bariatric Surgery and Modulation of Perceived Satiety

Recruiting
NCT04994665Not Applicable

Evaluation of Omentopexy on Gastro-oesophageal Reflux Following Sleeve Gastrectomy

Recruiting
NCT04938310Not Applicable

Impact of Wearing a Support Garment Following Parietal Gastrectomy

Terminated
NCT04168060Not Applicable

Crural Dissection in Sleeve Gastrectomy

Terminated
NCT01984762Not Applicable

Sleeve Gastrectomy and Roux-en-Y Gastric Bypass in the Treatment of Type 2 Diabetes Mellitus.

Recruiting
NCT06629662Not Applicable

Robotic Versus Laparoscopic Sleeve Gastrectomy

Recruiting
NCT02217943Not Applicable

Prospective Metabolic Surgery in T2DM Chinese Subjects

Completed
NCT06734273Early Phase 1

Randomized Control Trial of Sleeve Gastrectomy with Tirzepatide in Maximizing Weight Loss

Recruiting
NCT06527170

Improved Erectile Function After Bariatric Surgery: Role of Testosterone and Other Factors

Completed
NCT06499675

Prevalence of Steatosis and Steatohepatitis in Patients Undergoing Bariatric Surgery; a Biopsy-based Study

Completed
NCT03582748

Neuroimaging Predictors of Bariatric Surgical Outcome

Active Not Recruiting
NCT05611697Not Applicable

Laparoscopic Single Anastomosis Sleeve Ileal Bypass Versus Laparoscopic Sleeve Gastrectomy for Morbid Obesity

Recruiting
NCT05224791

A Retrospective Multicenter Comparison of Laparoscopic and Robotic-Assisted Roux-en-Y Gastrectomy

Recruiting
NCT02767505Not Applicable

Bypass Equipoise Sleeve Trial (BEST)

Active Not Recruiting
NCT05486169Not Applicable

Gastroesophageal Reflux Disease After Laparoscopic Sleeve Gastrectomy

Completed

Drug Details

Intervention Type
PROCEDURE
Total Trials
72